Preventing Drug Overdoses: Community Prevention and Response

The Preventing Drug Overdoses: Community Prevention and Response program is a federal grant opportunity administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the U.S. Department of Health and Human Services. SAMHSA’s mission centers on reducing the impact of substance use and mental illness on communities across the United States. This funding opportunity aligns with national priorities to address the opioid crisis and rising drug overdose deaths by supporting community-based strategies that expand access to life-saving interventions. The primary purpose of this program is to develop and implement comprehensive, community-wide overdose prevention initiatives. Funded projects are expected to expand access to FDA-approved opioid overdose reversal medications, such as naloxone, and integrate these tools into broader public health and community response systems. The program emphasizes prevention, rapid response, and community engagement, targeting populations at high risk of overdose and aiming to reduce mortality through timely intervention and coordinated care. Funding under this opportunity is intended to support a range of activities, including the procurement and distribution of overdose reversal medications, training for community members and first responders, public awareness campaigns, and partnerships with healthcare providers, harm reduction organizations, and local stakeholders. While specific allowable costs are not detailed in the forecast notice, SAMHSA grants typically require funds to be used in alignment with program objectives and federal cost principles. Notably, there is no cost sharing or matching requirement for this opportunity, reducing financial barriers for eligible applicants. Eligibility for this program is broad but limited to domestic public and private nonprofit entities, including faith-based organizations. This inclusive eligibility framework allows a wide range of community-based organizations, healthcare providers, and nonprofit institutions to apply, provided they operate within the United States and meet SAMHSA’s organizational requirements. The emphasis on nonprofit status reflects the program’s focus on public health and community service delivery. The application process will be formally announced upon release of the full Notice of Funding Opportunity (NOFO), which is estimated to be posted on May 29, 2026. At that time, applicants will be required to submit proposals through the appropriate federal grants platform, typically Grants.gov. Application components are expected to include a detailed project narrative, budget justification, and supporting documentation demonstrating organizational capacity and alignment with program goals. SAMHSA generally evaluates applications based on criteria such as need, approach, organizational capacity, and expected outcomes. As a forecasted opportunity, key dates such as the application deadline, award date, and project start date have not yet been specified. However, the forecast indicates a total program funding amount of $11,050,000 with an expected 13 awards, suggesting a competitive funding environment. Interested applicants are encouraged to monitor updates and prepare in advance for submission requirements. For additional information, applicants may contact Shannon Hastings at SAMHSA via phone or email. This program represents a critical federal investment in reducing overdose deaths and strengthening community-level public health responses nationwide.